Conferences

3DHEALS Startup Showcase: Singapore

3DHEALS is returning to Singapore once again to co-host an exciting start-up showcase event with NAMIC to connect local business leaders, innovation enthusiasts, investors, and entrepreneurs in the healthcare 3D printing, bioprinting, and medical technologies space. This showcase event is a premier opportunity to hear directly from founding team members to learn more about the thriving Singaporean start-up ecosystem as they strive towards shaping the future of patient care. In the lead up to the event, gain a deeper understanding of the contributing factors to Singapore’s start-up success through our in-depth guide found here.

Speakers:

Ben Holmes

CEO and Co-Founder of Nanochon

blank

Dr. Ben Holmes is an entrepreneur, medtech executive, inventor and scientist. He is the founder of Nanochon, which is commercializing a 3D printed implant for regenerating lost or damaged cartilage in joints. His academic background is in 3D printing and biomaterials for tissue engineering and regeneration.

Adam Jakus

Co-Founder and Chief Technology Officer of Dimension Inx

ADAM E. JAKUS, PH.D.

Dr. Adam Jakus is Co-Founder and Chief Technology Officer of Dimension Inx, a Chicago-based, advanced biomaterials and biofabrication company. As CTO, Adam leads Dimension Inx internal innovation, external collaborative projects, as well as manufacturing activities. For the past 11 years, Adam has been intimately involved with advanced, functional material design for 3D-printing and bioprinting, covering and developing new 3D-printable materials as diverse as metals and alloys, ceramics, graphene and nanotubes, extraterrestrial regoliths, gels, and advanced hard and soft tissue regenerative biomaterials – encompassing a materials-centric platform now collectively referred to 3D-Painting. With a Ph.D. in Materials Science and Engineering from Northwestern University and B.S. and M.S. degrees in Materials Science and Engineering from Georgia Tech, Adam is a Materials Engineer at heart and believes the future of medical and non-medical technologies lies in the development of new, advanced materials.

Chia Lye Peng

Co-Founder and CEO of FlexoSense

blank

Lye Peng has more than 25 years of multi-faceted Asia Pacific and global experiences in the MNC and SME environment; including technology licensing, business development, sales and marketing, e-commerce, learning & development and operations. Her intrapreneurial & enterprising skills have had provided opportunities in ground-breaking stretch goals initiatives, in collaboration with global colleagues across diverse cultures, perspectives and domain expertise. She brings these experiences and skillsets to FlexoSense as a co-founder & CEO where she hopes the Singapore-based company can create a global impact under UN Sustainable Development Goal (SDG) #3, Good Health and Well-Being. Encouraging a growth mindset, she is ever ready to champion bold ideas from colleagues that dovetail with this SDG #3. Having a family history of diabetes, the first area of impact the company hopes to make a difference is in the global diabetes problem.

Amrish Nair

Co-Founder and CEO of Biorithm

blank

Born and raised in Singapore, Amrish Nair received his B.Eng. and M.Eng. from the School of Electrical and Electronic Engineering at the Nanyang Technological University. His graduate studies research led him to numerous international publications and a US Patent on ECG signal analysis and monitoring. His research collaboration with TTSH cardiologist, Dr. David FOO and NTU supervisor Assoc. Prof. Pina Marziliano led him to spin-off BIORITHM, a medtech startup providing cutting-edge signal processing solutions in the fields of remote monitoring and wearable technology. Amrish Nair is passionate in developing medical device technologies for the well-being and health of patients. As one of the founding members of BIORITHM, Amrish and his team set out with the aim of making medical technology more affordable and available whilst pushing technological limits to greater progression.

Dr. Wei Jiang GOH

Co-Founder & Chief Executive Officer of Craft Health Pte Ltd

blank

Dr Wei Jiang GOH is currently the Co-Founder & Chief Executive Officer of Craft Health Pte Ltd, where he oversees business development and investor relations, helming the company through its fundraising rounds. Previously a National University of Singapore (NUS) Graduate School of Integrative Sciences & Engineering (NGS) PhD-MBA scholar where he earned his PhD and MBA with specialization in Finance, his research interests include formulation science and Bio-Nanotechnology. He has published more than 10 peer reviewed research articles and hold several patents. Prior to that, Wei Jiang graduated from NUS Pharmacy in 2012 and practiced as a registered pharmacist.

Prof. Huang Dejian

Co-Founder of Kosmode Health Singapore Pte Ltd

blank

Dejian was trained as a chemist with a PhD degree (1999) in inorganic chemistry from Indiana University and postdoctoral research experience (Chem Eng) from Massachusetts Institute of Technology. He began his independent research career in 2001 by venturing into the chemistry of food bioactive constituents for health promotion and disease prevention and plant proteins. Specifically: 

  • Chemistry of bioactive compounds in fruits and vegetables for controlling diabetes, anti-aging, antioxidants, anti-inflammation, anti-obesity 
  • Plant proteins for 3D printing of seafood mimics and scaffolds for cell-based meat culture and biomedical applications 

He has published over ~200 papers and was named by Thomson Reuters as a Highly Cited Researcher 2014 and 2015. Dejian is an associate editor of Journal of Functional Foods, and Frontiers in Nutrition Food Chem. He is a co-founder of Kosmode Health Singapore Pte Ltd (2016) (https://kosmodehealth.com/).

Mike Graffeo

CEO and Co-Founder of Fluidform 3D

blank

In over 20 years in the life sciences, Mike has brought four novel products through the FDA that have generated over $20 billion in sales in both startup and growth organizations. Throughout his career, he has worked on the forefront of medical technologies, translating highly complex products and clinical data into successful businesses, both in the US and around the world.

Timothy Chua

Digital Transformation Strategy and Biz Dev, HP Inc.

blank

“I am an amicable young multipotentialite who is eager to learn about everything and hence I always ask many questions. I have a strong desire to contribute towards Singapore’s transition from a linear economy to a circular one and truly believe that this is possible here through a combination of design, reverse logistics and regulation. I envision myself gaining industry experience in my early career before moving onto consultancy work, followed by policy making and finally educating the next generation in my late years.”

Dr. Ho Chaw Sing

Managing Director of NAMIC

blank

Dr Ho Chaw Sing is the co-founder Managing Director of NAMIC (National Additive Manufacturing Innovation Cluster), a Singapore government platform initiative to catalyse innovation and scale industrial adoption of digital additive manufacturing technologies. Since its inception in 2015, NAMIC has raised millions in public-private funding to catalyse various AM initiatives across several industry sectors. Before joining the public sector, he spent several years with HP Singapore and Chartered Semiconductor, where he undertook various executive roles in technology and product development, as well as supply chain and business operations. A technology-for-good advocate, Chaw Sing has been active in scouting and nurturing AM deep tech start-ups, contributing to the growing startup ecosystem in Singapore. Chaw Sing is the co-chair of the Singapore Standards AM Technical Committee, and sits in the ASTM International AM Centre of Excellence (AM CoE) Steering Committee. Chaw Sing earned his doctorate (Ph.D) in Electrical and Computer Engineering and Bachelor’s (honours) degree in Electrical Engineering with a major in Microelectronics from the National University of Singapore, where he is currently an adjunct Professor.

Moderators:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.

Mahendran V. Reddy

Mahendran Reddy

Mahendran Reddy is a highly driven professional with 20 years of international professional experience in the creative industries in both the private and public sectors.

As a trained architect and a media personality, he has held key strategic appointments in driving innovation and initiatives in the civil service, notably the establishment of the National Design Centre in Singapore.

At UCT, he has driven the adoption of Additive Manufacturing in its fledgling form in South East Asia mainly in the consumer segment of the business.

At NAMIC, he is actively involved in the adoption of Additive Manufacturing in the Industries by initiating collaborative research projects with Industry and Institutes of Higher Learning.

He brings with him an in-depth knowledge in management, government processes and procurement, design thinking skills and excellent interpersonal and professional competencies.

blank

3DHeals Melbourne – 3D MedTech Innovation

3DHeals Melbourne is returning in 2021 to highlight local collaborative innovations in health care 3D technologies and to provide a virtual platform to foster crosstalk between clinicians, academia, and industry. The focus for this event will be on the real-world applications of biomedical engineering as we will hear from leading experts in the fields of 3D printing, 3D modeling/digital design, medical devices, and implants, followed by a discussion panel to breakdown similar challenges that lie ahead and how best to synergize research and development efforts moving forward. 

3DHeals Melbourne welcomes all who are interested to learn more of the latest developments, practical applications, and future explorations of these exciting 3D medical technologies and how they can help shape the future of patient care.

Speaker info:

William Harley

William Harley

William Harley graduated with honors in medical biotechnology from the University of New South Wales. Currently, he is undertaking a Ph.D. at the University of Melbourne in acoustophoretic bioprinting. Stemming from his research experience in biomaterials, stem cells, and nanofabrication, he is driven by the clinical translation of personalized regenerative medicine. He is passionate about the innovation of 3D printing in healthcare and is determined to orchestrate a series of 3D HEALS events to engage in the Australian community.

Mark Roe

Managing Director of Fusetec

Mark Roe

Mark Roe, along with his business partner John Budgen founded Fusetec in April 2017, the business had a somewhat unconventional beginning. “When I was introduced to advanced manufacturing, the theory behind Industry 4.0 was compelling. I could really see a future in it,” said Roe. Once back in Australia, Mark considered the three major manufacturing industries in South Australia: aerospace, defense, and medical. He quickly landed on medical. “By opting to work in the medical industry, we could develop our own IP, with global applications.” It was then that he started canvassing medical professionals and academia to pinpoint that all-elusive problem to solve. The three most commonly cited issues were a lack of cutting guides, medical implants, and patient-specific models. However, he was not keen to pursue a business model based on personalized manufacturing. Mark leads the management team and passionately drives our Research & Development team, collaborating with Universities, Medical professionals, and Government entities worldwide.

Prof. Peter Lee

Professor in the Department of Mechanical Engineering at University of Melbourne/Director of ARC CMIT

blank

Prof. Peter Lee obtained his BEng in Mechanical Engineering (1st Class Hons. 1991) and PhD (1996) in Bioengineering from the University of Strathclyde, UK, and continued his post-doc in the same university from 1996–1998.

Professor Peter Lee is the Director of the Australian Research Council (ARC) Training Centre for Medical Implant Technologies and the Chief Investigator in the ARC Training Centre for Personalised Therapeutic Technologies. As Director of the ARC Training Centre for Medical Implant Technologies, he leads the largest industry-university-hospital partnership in Australia focusing on orthopaedic and maxillofacial implants to train a new generation of interdisciplinary engineers in biomechanics, materials and manufacturing for the orthopaedic and maxillofacial implant industry. He joined the University of Melbourne, Australia, as a Senior Lecturer in 2008, and was promoted to an Associate Professor in 2011 and a Professor in 2015. Since then he has held several leadership positions including Deputy Head and Acting Head of Department of Mechanical Engineering, and currently as the Deputy Head (Research) of Department of Biomedical Engineering and leads the Cell and Tissue Biomechanics Laboratory in Engineering, where his research aims to better understand the behaviour of biological cells and tissues under mechanical forces. He has authored more than 140 publications in journals, conference proceedings and books. He is a regular reviewer for journals and grant bodies and currently the Deputy Editor for Journal of Orthopaedic Surgery and Research (Springer Nature), and Associate Editor for Frontiers in Pharmacology (Translational Pharmacology).

A/Prof. Kate Fox

Associate Dean of Higher Degrees by Research/ and Associate Professor within the School of Electrical and Biomedical Engineering at RMIT

blank

Kate Fox is an Associate Professor in the School of Electrical and Biomedical Engineering. Kate is a biomedical engineer with significant experience and expertise in coatings and implant fabrication for orthopedic applications. Prior to joining RMIT, she was part of the Bionic Eye Project working to develop a high acuity diamond electrode capable of electrically stimulating retinal tissue. She is a reformed patent attorney and can advise on the patentability of research. Kate is committed to the real-world application of biomedical engineering and was shortlisted for the AFR 2018 Emerging Leader in Higher Education Award. Kate is experienced in working in highly complex, transdisciplinary projects, coordinating research teams, and providing the surgical integration necessary to transition an engineered product into a surgically feasible product. She has successfully attained over A$6M direct and in-kind funding. Kate is CI in the ARC ITTC in Additive Biomanufacturing and a 2019-2020 Superstar of STEM.

Dr. Lindsay Bussau BSc (Hons), PhD

Applications and Customer Support Manager, Optiscan Pty Ltd

blank

The talk will discuss endomicroscopy and the basics of Optiscan’s handheld fibre-optic confocal microscope. Dr. Bussau will demonstrate the Optiscan FIVE2 (Viewnvivo) handheld confocal imaging system and will discuss the potential for use of confocal endomicroscopy to image tissue structure in vivo. Dr Bussau did his post-doctorate research on confocal laser fiber optic imaging and has 25 years of experience with the technology.

Dr. Yunlong Tang

Joint lecturer in the Department of Mechanical and Aerospace Engineering and the Department of Materials Science and Engineering Monash University

blank

Dr. Yunlong Tang joined the Faculty of Engineering at Monash University in Feb 2020. Currently, he is a lecturer jointly appointed by the Department of Mechanical and Aerospace Engineering and the Department of Materials Science and Engineering.  His major research interests are in the general field of design and manufacturing, including smart manufacturing, additive manufacturing, and its related design methods, sustainable design and manufacturing, AI-aided design, CAD/CAM, design and fabrication of lattice or cellular materials. Yunlong has over nine years of international R&D experience, participating in several national research and industrial projects from China, Canada, Europe, and Singapore. He obtained his Ph.D. degree from McGill University, Canada in 2017, M.Sc. degree from Beijing University of Aeronautics and Astronautics, China in 2013, B.Sc. degree from Harbin Institute of Technology in 2010. Before he coming to Monash, he did one and half year Post-Doc research at Singapore University of Technology and Design and was working on the next generation of CAD software for AM. He is a leading developer of an open-source lattice structure design and optimization software called INTRALATTICE PRO which has been downloaded more than ten thousand times by now.

Tam C. Nguyen

Associate Professor and Deputy Director of Research at St Vincent’s Hospital Melbourne

blank

Associate Professor Tam Nguyen has over 20 years of working in the healthcare, health & medical research environment including tertiary teaching hospitals and research institute across Australia.

Tam is the Deputy Director of Research at St Vincent’s Hospital Melbourne, one of the largest tertiary teaching and research hospitals in Melbourne – responsible for the organisation’s research strategy, research ethics and governance, clinical trials, research innovation and development.

Tam serves as non-executive director and advises several medtech and health tech start-ups on clinical and commercialisation strategy. He is a regular invited speaker on a broad range of topics at national and international conferences. He holds academic appointment with Melbourne University’s Medical School and Monash University’s Medical School – two of the world top 30 (and APAC top 5) medical schools.

blank

blank

3DHEALS2018 Summit Recordings

blank


Download 3DHEALS2018 agenda:

The 3DHEALS2018 conference has gathered 45 cross-disciplinary influencers from all over the world to speak on the current and future trends of this burgeoning field, which aims to transform trillion-dollar industries including the manufacturing, medical device, and pharmaceutical industries. The group shares the belief that these technologies will be able to solve many healthcare challenges that existing technologies cannot, including; lowering care costs, increase access to care, and improving care outcomes. 
This two-day activity-filled event includes a Day 1 hands-on workshop to continue the company’s efforts in building and expanding end-user base among medical and dental healthcare providers, but also provide organizations with how-tos to become early adopter and users of 3D printing and bioprinting technologies. Notably, workshops include:

  • Valerie Cooper, also known as the “Denture Queen”, will lead a 1.5 hours hands-on session to teach attendees on how to create dentures with a new digital workflow that can potentially solve the current crisis where there is a lack of affordable denture providers and care.
  • Mayasari Lim from SE3D will also provide a hands-on workshop to teach attendees the basics of bioprinting, a technology that has the potential to solve current organ transplant shortage crisis.
  • Hannah Riedle from FAU Erlange-Nuremberg (Munich, Germany) will provide a 1.5 hour long hands-on workshop to share her digital workflow of generating 3D printed medical anatomical models using open source software. 
  • Erik Birkenederfrom Nixon Peabody LLP will provide an overview on how to protect intellectual properties for the entrepreneurs in this new space.

The attendees are invited to the night reception immediately following the workshops to raise money for two non-profit organizations, Limbforge and the Victoria Hand Project. The special press release for the fundraising event is here.
Day 2 is the main conference day where 40+ industry leaders and innovators will speak. The event’s keynote speaker Mr. Jeffrey Sorenson from Terarecon will start the day with his insights on how an integrated digital system composed of 3D visualization, 3D printing, and artificial intelligence will impact the future of healthcare. Two parallel tracks of expert panel presentations and QA sessions will then ensue.
Among the many topics that will be explored in-depth during the conference, notable ones include:

  • 3D printing in healthcare organizations– Include presentations from multiple institutions with variable resources, including Stanford Healthcare, Children’s Hospital of Phoenix, and Children’s Hospital Boston.
  • Legal and regulatory updates– FDA and CE updates on 3D printed medical devices, IP and liability concerns in healthcare 3D printing and bio-printing innovations. Presenting companies include UL, JNJ, ReedSmith, Nixon Peabody, and Squire Patton Boggs.
  • Digital dentistry– Include current and future trends of implementing 3D printing in dentistry and becoming part of a growing dental in-office digital manufacturing ecosystem.
  • Advanced materials updates– Include current and future material selection of biocompatible polymers and metals for 3D printed medical devices. This powerful panel includes Nag Patibandla from Applied MaterialsRik Jacobs from NextDent (now 3D Systems), Karsten Schlichter from Elkem Silicones, and Ankit Saharan from EOS.
  • Bioprinting panel– includes perspectives of how, and how soon bioprinting will impact the future of organ transplant and pharmaceutical research form a panel of bioprinting startups including Aspect BiosystemsPrellis Biologics, and pharmaceutical startup Viscient Biosciences (partner with Organovo), as well as Medtronics.
  • Orthotics and Prosthetics panel– includes updates from founders of Standard Cyborg, WiDE, the Victoria Hand Project.
  • Orthopedics panel– Includes presentations by UCSF orthopedics and AnatomicsRx, a company that successfully created the first customized sternum implant in the United States.
  • International panel â€“ Includes individual to organizational insights on healthcare 3D printing and bioprinting innovations all over the world.

During lunchtime, the annual global pitch competition will invite 10 startups from healthcare 3D printing, bioprinting, and related 3D visualization technologies such as VR/AR to pitch in front a group of investors including GE Ventures, Asimov Ventures, Digital Industrialist, and other Silicon Valley investors.
The event will conclude with a fireside chat between Dr. Paul D’Urso, CEO of AnatomicsRx, a company that successfully created the first customized sternum implant in the United States, and Penelope Heller, the patient who successfully received the treatment. The presentation aims to provide the audience a real-life example of not only how 3D printing innovation in health care improves patient care, but also the many challenges faced by both the patients and companies to access and implement these innovations.

Media Coverage:

3DHeals 2018 to foster collaboration in medical 3D printing

Nia’s CEO Interviewed For 3DHEALS 2018 Conference

3DHEALS2020

3DHEALS2020 Summit Recordings

3DHEALS2020

3DHEALS2020 (June 5th-6th, 2020 )was the largest virtual summit this year, in the space of healthcare 3D printing/bioprinting, or elsewhere. This incredible virtual two-day summit gathered more than 70 world experts, 22 sessions. It is one of the most well-curated events that engage the audience to learn, think, and re-invent future healthcare.

We believe the recordings of this summit not long serve as a record of technological advanced in time and space, but also a good starting point for anyone who is interested in working and investing in this unique space.

blank

Download Agenda here:

3D Printing Ti6Al4V Orthopaedic Implants: As Easy as Counting 1-2-3 (Video)

Media Coverage:

3DHEALS2020: Thank You!

Adventure for Life: Why You Really Should “Attend” 3DHEALS2020 Live

3DHEALS 2020 Virtual Medical Summit: 3D-Printed Materials in Healthcare (3DPrint.com)

Reimagining Healthcare With 3D Printing (SME)

3DHEALS 2020 Virtual Medical Summit: Comprehensive Look at Craniomaxillofacial 3D Printing (3DPrint.com)

blank

3DHEALS Los Angeles: Discovering Healthcare 3D Printing

Live recording of past event in Los Angeles, September 26th, 2018.

Live Event Agenda:

7:00-7:10 PM Dr.  Jenny Chen  (3DHEALS)
7:10-7:15  PM Q & A
7:15-7:25 PM Mr. Steven Morris (BIOLIFE4D)
7:25-7:30 PM Q &A
7:30-7: 40 PM Dr. Sanjay Sinha (UCLA)
7:40- 7:45 PM Q & A
7:45-7:55  PM Dr. Ali Khademhosseini (UCLA)
7:55-8:00 PM Q&A
8:00-8: 10 PM Dr. August de Oliveira
8:10-8:15 PM Q&A
8:15-8:45 PM Panel Q&A

blank
Mr. Steven Morris 

BIOLIFE4D Founder and CEO Steven Morris possess more than 20 years of extensive experience in precision manufacturing, including 15 years serving as President of privately-held Inland Midwest Corporation (IMC) where he led the company’s transformation into a premier, state-of-the-art facility catering exclusively to the medical technologies industry. After several years of high profitability, Steven negotiated a successful exit strategy and sold the company in 2011.  After remaining on as President for over two years, he left and started BIOLIFE4D, an emerging biotech company working on the technology to bioengineer a human heart viable for transplantation using a patient’s own cells. His diverse and comprehensive knowledge of medical devices, processes optimization, and medical technologies will be extremely beneficial to the success of BIOLIFE4D.

Dr. Ali Khademhosseini

Levi Knight Chair. Professor of Bioengineering, Chemical Engineering, and Radiology at UCLA, Previously @Harvard and @MIT for 16 years, biomedical researcher, innovator, mentor, world traveler, educator, ACS Nano Assoc. Editor

Dr. Sanjay Sinha
blank
Dr. Sanjay Sinha is an Interventional Pediatric Cardiologist and Assistant Professor of Pediatrics at UC Irvine and UCLA Mattel Children’s Hospital. He completed his medical school at the University of Arizona college of medicine and then moved to Los Angeles for his training. He completed his pediatric residency, pediatric cardiology fellowship, and extra interventional procedural training at UCLA Mattel Children’s hospital. His research interests are in transcatheter valve replacement in congenital heart disease. He has worked extensively in the area of 3D modeling for both surgical and interventional procedural planning and is currently the co-founder of the Congenital and Structural 3D Printing Program at UCLA.

Dr. August De Oliveira
blank
Dr. August De Oliveira graduated in the top 10% of his class at the University of Washington School of Dentistry in 1997. After moving to Los Angeles from Seattle, Dr. de Oliveira did an optional additional year in a General Practice Residency at the VA Sepulveda where he learned advanced techniques in Endodontics (Root Canals), Dental Implants, and Restorative Dentistry. Dr. de Oliveira lectures weekly all over the nation on three subjects: CAD/CAM (same day crowns), CBCT (3D x-rays), and dental implants. On implants, he lectures from the basics of single-tooth implants to advanced Edentulous (no teeth) treatment. He has been published in many peer-reviewed journals and is widely recognized as a pioneer in CBCT Guided Surgery. Dr. de Oliveira has developed software for numerous dental companies and has authored two textbooks on dental implants.